Abstract:Articular cartilage repair remains a clinical and scientific challenge with increasing interest focused on the combined techniques of gene transfer and tissue engineering. Transforming growth factor beta 1 (TGF-beta(1)) is a multifunctional molecule that plays a central role in promotion of cartilage repair, and inhibition of inflammatory and alloreactive immune response. Cell mediated gene therapy can allow a sustained expression of TGF-beta(1) that may circumvent difficulties associated with growth factor delivery. The objective of this study was to investigate whether TGF-beta(1) gene modified mesenchymal stem cells (MSCs) could enhance the repair of full-thickness articular cartilage defects in allogeneic rabbits. The pcDNA(3)-TGF-beta(1) gene transfected MSCs were seeded onto biodegradable poly-L-lysine coated polylactide (PLA) biomimetic scaffolds in vitro and allografted into full-thickness articular cartilage defects in 18 New Zealand rabbits. The pcDNA(3) gene transfected MSCs/biomimetic scaffold composites and the cell-free scaffolds were taken as control groups I and II,respectively. The follow-up times were 2, 4, 12 and 24 weeks. Macroscopical, histological and ultrastructural studies were performed. In vitro SEM studies found that abundant cartilaginous matrices were generated and completely covered the interconnected pores of the scaffolds two weeks post-seeding in the experimental groups. In vivo, the quality of regenerated tissue improved over time with hyaline cartilage filling the chondral region and a mixture of trabecular and compact bone filling the subchondral region at 24 weeks post-implantation. Joint repair in the experimental groups was better than that of either control group I or II, with respect to: ( 1) synthesis of hyaline cartilage specific extracellular matrix at the upper portion of the defect; ( 2) reconstitution of the subchondral bone at the lower portion of the defect and ( 3) inhibition of inflammatory and alloreactive immune responses. The transfected MSCs overexpressed their TGF-beta(1) gene products for at least 4 weeks in vivo. The control defects were filled with a mixture of fibrous and fibrocartilaginous tissue. The TGF-beta(1) gene transfected MSCs/poly-L-lysine coated PLA composite allografts used in this study are effective for articular cartilage repair. This novel TGF-beta(1) gene enhanced tissue engineering strategy may be of potential benefit to enhancing the repair of damaged articular cartilage, especially such damage caused by degenerative disease.

A Novel Nanometer Non-Viral Gene Transfer System for Cartilage Defects

In Vivo and in Vitro Cartilage Transfection by a Non-Viral Gene Delivery System

Highly efficient healing of critical sized articular cartilage defect in situ using a chemically nucleoside-modified mRNA-enhanced cell therapy

Cartilage-Targeting Mrna-Lipid Nanoparticles Rescue Perifocal Apoptotic Chondrocytes for Integrative Cartilage Repair

Experimental Study of Chitosan Mediated in Vivo Igf-1 Gene Transfection for the Treatment of Cartilage Defect (local Administration of Chitosan/igf-1 Complex Treat Cartilage Defect)

In vivo restoration of full-thickness cartilage defects by poly(lactide-co-glycolide) sponges filled with fibrin gel, bone marrow mesenchymal stem cells and DNA complexes.

Ectopic chondrogenesis of nude mouse induced by nano gene delivery enhanced tissue engineering technology.

Nanopolymers Delivery of the Bone Morphogenetic Protein-4 Plasmid to Mesenchymal Stem Cells Promotes Articular Cartilage Repair in Vitro and in Vivo

Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor-β1-transfected mesenchymal stem cells grown on chitosan scaffolds

Integration of C-type Natriuretic Peptide Gene-Modified Bone Marrow Mesenchymal Stem Cells with Chitosan/silk Fibroin Scaffolds As a Promising Strategy for Articular Cartilage Regeneration

Constructing Gene-Enhanced Tissue Engineering for Regeneration and Repair of Osteochondral Defects.

Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor β<sub>1</sub> gene

An Experimental Research Of Repairing Osteochondral Defect In A Rabbit Model With Tissue-Engineered Nano-Hydroxyapatite/Chitosan Graft

Repair of rabbit cartilage defect based on the fusion of rabbit bone marrow stromal cells and Nano-HA/PLLA composite material

Porous Chitosan Scaffolds With Embedded Hyaluronic Acid/Chitosan/Plasmid-Dna Nanoparticles Encoding Tgf-Beta 1 Induce Dna Controlled Release, Transfected Chondrocytes, And Promoted Cell Proliferation

A Cell-Free Therapy for Articular Cartilage Repair Based on Synergistic Delivery of SDF-1 & KGN with HA Injectable Scaffold

A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system

Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation.

Novel Nano-Microspheres Containing Chitosan, Hyaluronic Acid, and Chondroitin Sulfate Deliver Growth and Differentiation Factor-5 Plasmid for Osteoarthritis Gene Therapy

Combined Effects of Connective Tissue Growth Factor-Modified Bone Marrow-Derived Mesenchymal Stem Cells and Naoh-Treated Plga Scaffolds on the Repair of Articular Cartilage Defect in Rabbits

Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-β1 for chondrocytes proliferation